In hepatocellular carcinoma, Zuckerman et al. reported distinct LPAR3 expressions within the tumor and normal tissues, and LPAR3 may enhance liver cancer migration via the LPAR3-Gi-ERK/MAPK pathway [56]. This evidence concerns the gene LPAR3 and hepatocellular carcinoma.